Back
Phathom Pharmaceuticals Stock Price Chart

Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
25
PHAT
Phathom Pharmaceuticals
Last Price:
$4.22
Seasonality Move:
0.35%
7 Day Trial
ALL ACCESS PASS
$
7

Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio-
The current trend is relatively stagnant and PHAT is experiencing slight selling pressure.
Phathom Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.74 | Buy |
20-day SMA: | 3.5 | Buy |
50-day SMA: | 4.48 | Sell |
200-day SMA: | 9.66 | Sell |
8-day EMA: | 3.81 | Buy |
20-day EMA: | 3.72 | Buy |
50-day EMA: | 4.39 | Sell |
200-day EMA: | 7.69 | Sell |
Phathom Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.12 | Sell |
Relative Strength Index (14 RSI): | 50.84 | Buy |
Chaikin Money Flow: | -437797 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.92 - 4.28) | Buy |
Bollinger Bands (100): | (4.04 - 6.86) | Sell |
Phathom Pharmaceuticals Technical Analysis
May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 3.90 while PHAT 8-day simple moving average is 3.74, which is a Buy signal.
-
The stock price of PHAT is 3.90 while Phathom Pharmaceuticals 20-day SMA is 3.50, which makes it a Buy.
-
Phathom Pharmaceuticals 50-day simple moving average is 4.48 while PHAT share price is 3.90, making it a Sell technically.
-
PHAT stock price is 3.90 and Phathom Pharmaceuticals 200-day simple moving average is 9.66, creating a Sell signal.
PHAT Technical Analysis vs Fundamental Analysis
Sell
25
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a SellThe current Phathom Pharmaceuticals [PHAT] share price is $3.90. The Score for PHAT is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
272.3M
Price in USD:
3.90
Share Volume:
1.2M
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
2.21
Sell
25
Phathom Pharmaceuticals (PHAT)
is a Sell
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?The Phathom Pharmaceuticals stock price is 3.90 USD today.
-
Will PHAT stock go up or go down?Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Phathom Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 3.90 while PHAT 8-day exponential moving average is 3.81, which is a Buy signal.
-
The stock price of PHAT is 3.90 while Phathom Pharmaceuticals 20-day EMA is 3.72, which makes it a Buy.
-
Phathom Pharmaceuticals 50-day exponential moving average is 4.39 while PHAT share price is 3.90, making it a Sell technically.
-
PHAT stock price is 3.90 and Phathom Pharmaceuticals 200-day simple moving average is 7.69, creating a Sell signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.92 per share, an increase next quarter of $0.37 per share, an increase this year of $1.80 per share, and an increase next year of $2.44 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
-
PHAT Moving Average Covergence Divergence (MACD) indicator is -0.12, suggesting Phathom Pharmaceuticals is a Sell
-
Phathom Pharmaceuticals Relative Strength Index (RSI) is 50.84, which suggest Phathom Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Phathom Pharmaceuticals is (2.92 - 4.28), which suggest Phathom Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Phathom Pharmaceuticals is (4.04 - 6.86), which suggest Phathom Pharmaceuticals is a Sell
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.